#clinical trials

Frost & Sullivan today released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with ...

- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of ...

-AGC Asahi Glass ("AGC"), a world-leading manufacturer of glass, chemicals and high-tech materials, announced on ...

- Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain ...

U.S. Vice President Joe Biden said  the "moonshot" initiative he leads aimed at finding cures for cancer was "the ...

- The results of a recent multi-center clinical study show, for the first time, that oral administration ...

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

- Mitsubishi Tanabe Pharma Corporation (TSE: 4508), and Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd ...

-606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 ...

- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...

- Australian-listed Holista CollTech Limited (ASX: HCT) announced today a global scientific breakthrough, validated ...

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...

based companion diagnostic (CDx) in immuno-oncologyDARMSTADT, Germany & NEW YORK--(Antara/BUSINESS WIRE.

- 60 Degrees Pharmaceuticals, (60P), a company focused on development of therapeutics for tropical ...

-  The team of seven researchers from Malaysia, the Netherlands, Spain and the UK, including Professor Yasin Temel ...